The first declipseSPECT in Asia has been introduced to Health Care Global’s (HCG) Bangalore facility to aid cancer treatments. The radio-guided surgical instrument provides 3D imaging and guidance support for minimally invasive tumor surgery.

Dr. Joerg Traub from the German manufacturer, SurgicEye GmbH, announced the launch of the new cancer services on Thursday, Aug. 29, 2013, saying:I am convinced that HCG is the best location for the first declipseSPECT installation in Asia. The declipseSPECT will add one more innovation to HCG’s high quality service, providing 3D imaging and guidance support for least invasive surgery and quality assurance in the operating room to document the complete removal.This cutting-edge technology is principally used for breast cancer, oral cancer, gynaecological cancers and skin cancer. Dr Mahesh Bandemegal, a consultant oncologist at HCG Bangalore, said the declipseSPECT was “the most accurate way of detecting and avoiding false negativity” in the localization of lymph nodes.The declipseSpect is a handheld gamma probe device for radio-guided surgery. Sentinel lymph node biopsy is the minimally invasive procedure used to determine the extent of cancer in the body. The large 3D viewing screen on the declipseSPECT is ideal for optimizing laparascopic procedures and ensure the best possible patient outcome.The oncology surgeons are delighted to have this new equipment in Bangalore as it takes the guesswork out of locating the sentinel lymph node, not only giving a 3D location, but also advising of the depth at which the lymph node is located.

For further information contact HCG at:  #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bangalore – 560 027 / Ph : 080 40206000